Skip to main content
Clinical Trials/NCT07118995
NCT07118995
Active, not recruiting
Not Applicable

Anatomical Feasibility of the Braile Off-the-Shelf Multi-Branched Endograft for the Treatment of Thoracoabdominal Aneurysm

Braile Biomedica Ind. Com. e Repr. Ltda.1 site in 1 country100 target enrollmentStarted: August 1, 2025Last updated:

Overview

Phase
Not Applicable
Status
Active, not recruiting
Sponsor
Braile Biomedica Ind. Com. e Repr. Ltda.
Enrollment
100
Locations
1
Primary Endpoint
Anatomical feasibility and applicability of off-the-shelf multi-branched endografts from two device models

Overview

Brief Summary

The objective of this retrospective observational study is to evaluate the theoretical anatomical suitability of the new Braile off-the-shelf multi-branched endograft in patients with thoracoabdominal aneurysm. One hundred preoperative contrast-enhanced computed tomography angiographies (CTAs) from patients previously treated with a custom-made endograft will be analyzed. The hypothesis is that a significant proportion of these patients will have anatomical features compatible with the use of the new endograft.

Study Design

Study Type
Observational
Observational Model
Case Only
Time Perspective
Retrospective

Eligibility Criteria

Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Preoperative CTA images from patients previously treated with Braile's custom-made multi-branched endograft for thoracoabdominal aneurysm.
  • Contrast-enhanced CTAs covering the thorax, abdomen, and pelvis, with thin slices of 1 to 2 mm, available in Braile's imaging database.

Exclusion Criteria

  • Exams with incomplete or inadequate images, defined as CTAs with slice thickness greater than 2 mm

Outcomes

Primary Outcomes

Anatomical feasibility and applicability of off-the-shelf multi-branched endografts from two device models

Time Frame: completion of the anatomical assessment

Number of patients with anatomical characteristics suitable for the theoretical use of the new Braile off-the-shelf multi-branched endograft.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Braile Biomedica Ind. Com. e Repr. Ltda.
Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials